BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33432966)

  • 1. Expression profiling of some Acute Myeloid Leukemia - associated markers to assess their diagnostic / prognostic potential.
    Mousa NO; Gado M; Assem MM; Dawood KM; Osman A
    Genet Mol Biol; 2021; 44(1):e20190268. PubMed ID: 33432966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Using next generation sequencing technology to analyze gene mutations in patients with acute myeloid leukemia and the impact on prognosis].
    Zhao CX; Wang JM; Li JM; Zou SH; Chen FY; Liang AB; Hou J; Hu XX; Zhang YX; Gu SY; Zhu JY; Li P; Du J; Yang YN; Qin YW; Wang XR; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3145-3151. PubMed ID: 31694105
    [No Abstract]   [Full Text] [Related]  

  • 3. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
    Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML).
    Köhler T; Schill C; Deininger MW; Krahl R; Borchert S; Hasenclever D; Leiblein S; Wagner O; Niederwieser D
    Leukemia; 2002 Jan; 16(1):22-9. PubMed ID: 11840259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
    Fang Z; Wang X; Wu J; Xiao R; Liu J
    Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.
    Handschuh L; Wojciechowski P; Kazmierczak M; Marcinkowska-Swojak M; Luczak M; Lewandowski K; Komarnicki M; Blazewicz J; Figlerowicz M; Kozlowski P
    J Transl Med; 2018 Aug; 16(1):232. PubMed ID: 30126426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.
    Niu Y; Yang X; Chen Y; Jin X; Xie Y; Tang Y; Li L; Liu S; Guo Y; Li X; Duan L; Wang H
    Clin Transl Oncol; 2019 Sep; 21(9):1186-1196. PubMed ID: 30694461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid Leukemia Patients.
    Jiang H; Li C; Liu Z; Shengjing Hospital ;
    Acta Haematol; 2020; 143(1):51-59. PubMed ID: 31434075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsins B and L in peripheral blood mononuclear cells of pediatric acute myeloid leukemia: potential poor prognostic markers.
    Jain M; Bakhshi S; Shukla AA; Chauhan SS
    Ann Hematol; 2010 Dec; 89(12):1223-32. PubMed ID: 20567828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
    Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
    J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.
    Del Poeta G; Bruno A; Del Principe MI; Venditti A; Maurillo L; Buccisano F; Stasi R; Neri B; Luciano F; Siniscalchi A; de Fabritiis P; Amadori S
    Curr Cancer Drug Targets; 2008 May; 8(3):207-22. PubMed ID: 18473734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative meta-analysis of differential gene expression in acute myeloid leukemia.
    Miller BG; Stamatoyannopoulos JA
    PLoS One; 2010 Mar; 5(3):e9466. PubMed ID: 20209125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of matrix metalloproteinase-7 and matrix metalloproteinase-15 in acute myeloid leukemia.
    Wu Y; Pan S; Leng J; Xie T; Jamal M; Yin Q; Li J; He C; Dong X; Shao L; Zhang Q
    J Cell Biochem; 2019 Jun; 120(6):10613-10624. PubMed ID: 30809850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of SNAI1 and ZEB1 genes in acute myeloid leukemia patients.
    Shousha WG; Ramadan SS; El-Saiid AS; Abdelmoneim AE; Abbas MA
    Mol Biol Rep; 2019 Aug; 46(4):4625-4630. PubMed ID: 31055699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
    Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
    BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.
    Thol F; Friesen I; Damm F; Yun H; Weissinger EM; Krauter J; Wagner K; Chaturvedi A; Sharma A; Wichmann M; Göhring G; Schumann C; Bug G; Ottmann O; Hofmann WK; Schlegelberger B; Heuser M; Ganser A
    J Clin Oncol; 2011 Jun; 29(18):2499-506. PubMed ID: 21576631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
    Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
    Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
    Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
    Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HO-1, RET and PML as possible markers for risk stratification of acute myelocytic leukemia and prognostic evaluation.
    Yu M; Wang J; Ma D; Chen S; Lin X; Fang Q; Zhe N
    Oncol Lett; 2015 Nov; 10(5):3137-3144. PubMed ID: 26722301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High bax expression is a good prognostic indicator in acute myeloid leukaemia.
    Ong YL; McMullin MF; Bailie KE; Lappin TR; Jones FG; Irvine AE
    Br J Haematol; 2000 Oct; 111(1):182-9. PubMed ID: 11091199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.